Clinical Trial Update: Study of Lenalidomide/Rituximab Maintenance for Transplantation Ineligible Patients With PCNSL. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating maintenance therapy with lenalidomide and rituximab for patients with primary central nervous system lymphoma who are ine…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• Revlimid (lenalidomide)
• Rituxan (rituximab)

Snippet

Sponsor: Kim, Seok Jin | Conditions: Primary CNS Lymphoma | Phase 2 | Status: RECRUITING